Tumor necrosis factor antagonists in the treatment of multicentric reticulohistiocytosis: Current clinical evidence

被引:15
作者
Zhao, Hongjun [1 ]
W, Chun Mei [1 ]
Wu, Mengyun [1 ]
Zhou, Yaou [1 ]
Zhu, Honglin [1 ]
Li, Yisha [1 ]
You, Yunhui [1 ]
Luo, Hui [1 ]
Wang, Lijing [2 ]
Zuo, Xiaoxia [1 ]
机构
[1] Cent S Univ, Dept Rheumatol & Immunol, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Dept Gerontol, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
关键词
muticentric reticulohistiocytosis; tumor necrosis factor-alpha; anti-tumor necrosis factor-alpha agents; infliximab; RHEUMATOID-ARTHRITIS; ANTI-TNF; INFLIXIMAB; THERAPY; IMMUNOGENICITY; COMBINATION; EXPRESSION;
D O I
10.3892/mmr.2016.5253
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multicentric reticulohistiocytosis (MRH) is a rare and debilitating systemic disorder characterized by cutaneous nodules and destructive polyarthritis. Due to its unknown etiology, the treatment of MRH varies with different rates of success, which causes treatment options to be rather independent and empirical. In the present study, a case of a 48-year-old woman with a 12-month history of polyarthralgia and skin nodules was reported. Biopsy samples, which were obtained from her skin eruption exhibited dermal infiltration with histiocytes and multinucleated giant cells. Immunohistochemical staining indicated positivity for CD68. The patient was diagnosed with MRH and treated with a combination therapy of infliximab, prednisolone and methotrexate. Her symptoms improved markedly within 2 weeks. Following the results of this case study, a systematic review of 17 cases of MRH treated with tumor necrosis factor (TNF) antagonists was performed, and the efficacy of anti-TNF treatment in MRH was analyzed.
引用
收藏
页码:209 / 217
页数:9
相关论文
共 36 条
[1]   A case of multicentric reticulohistiocytosis [J].
Baek, In-Woon ;
Yoo, Sang Hoon ;
Yang, Hyun ;
Park, Jeongmi ;
Kim, Ki-Jo ;
Cho, Chul-Soo .
MODERN RHEUMATOLOGY, 2017, 27 (01) :165-168
[2]   Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature [J].
Behrens, Frank ;
Canete, Juan D. ;
Olivieri, Ignazio ;
van Kuijk, Arno W. ;
McHugh, Neil ;
Combe, Bernard .
RHEUMATOLOGY, 2015, 54 (05) :915-926
[3]   Multicentric reticulohistiocytosis with elevated cytokine serum levels [J].
Bennassar, Antoni ;
Mas, Antoni ;
Guilabert, Antonio ;
Julia, Marc ;
Manuel Mascaro-Galy, Jose ;
Herrero, Carmen .
JOURNAL OF DERMATOLOGY, 2011, 38 (09) :905-910
[4]   Healing of Erosive Disease in Multicentric Reticulohistiocytosis [J].
Broadwell, Aaron W. ;
Calamia, Kenneth T. ;
Kransdorf, Mark J. ;
Ginsburg, William W. .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) :1366-1367
[5]  
Chauhan A, 2007, J NATL MED ASSOC, V99, P678
[6]  
Chiba Emiko, 2011, Nihon Naika Gakkai Zasshi, V100, P483
[7]   MULTICENTRIC RETICULOHISTIOCYTOSIS ASSOCIATED ARTHRITIS RESPONDING TO ANTI-TNF AND METHOTREXATE [J].
De Knop, K. J. ;
Aerts, N. E. ;
Ebo, D. G. ;
Van Offel, J. F. ;
Stevens, W. J. ;
De Clerck, L. S. .
ACTA CLINICA BELGICA, 2011, 66 (01) :66-69
[8]   Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists [J].
de Vries, Hilbert S. ;
van Oijen, Martijn G. H. ;
Driessen, Rieke J. B. ;
de Jong, Elke M. G. J. ;
Creemers, Marjonne C. W. ;
Kievit, Wietske ;
de Jong, Dirk J. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (01) :7-19
[9]   Tumor necrosis factor and its blockade in granulomatous infections: Differential modes of action of infliximab and etanercept? [J].
Ehlers, S .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S199-S203
[10]   Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients [J].
Finckh, Axel ;
Dudler, Jean ;
Wermelinger, Felix ;
Ciurea, Adrian ;
Kyburz, Diego ;
Gabay, Cem ;
Bas, Sylvette .
JOINT BONE SPINE, 2010, 77 (04) :313-318